The Amyloidosis Forum: a public private partnership to advance drug development in AL amyloidosis | Orphanet Journal of Rare Diseases | Full Text

The Amyloidosis Forum: a public private partnership to advance drug development in AL amyloidosis | Orphanet Journal of Rare Diseases | Full Text

The Amyloidosis Forum: a public private partnership to advance drug development in AL amyloidosis

Immunoglobulin light chain (AL) amyloidosis is a rare, multi-systemic disorder characterized by two disease processes: an underlying plasma cell dyscrasia that provides the source of pathologic light chains, a...

Authors:Isabelle Lousada

Citation:Orphanet Journal of Rare Diseases 2020 15:268

Content type:Review

 

Published on: 29 September 2020

• ViewFull Text
 
• ViewPDF